Jubilant Pharmova receives ratings for proposed NCDs of Rs 1400 cr
(21 Oct 2026)
Back
| Jubilant Pharmova announced that India Ratings and Research has assigned the credit rating IND AA+; Stable to the company's proposed non-convertible debentures of Rs 1400 crore. |